Figure 4
(A) Primary monitoring parameters during the first 24 h following JWH-182 intravenous administration. (B) General health parameters monitored for 14 days following JWH-182 intravenous administration.
Figure 4 | Scientific Reports
(A) Primary monitoring parameters during the first 24 h following JWH-182 intravenous administration. (B) General health parameters monitored for 14 days following JWH-182 intravenous administration.
